Filter
1111
Filtered Results: 1111
Text search:
vaccine
trial
Featured
Recommendations
139
New Publications
237
Language
Document type
No document type
479
Studies & Reports
208
Guidelines
192
Manuals
68
Fact sheets
65
Strategic & Response Plan
41
Situation Updates
18
Training Material
14
Resource Platforms
12
Infographics
6
Videos
5
Brochures
2
App
1
Countries / Regions
Global
51
India
37
Kenya
26
Sierra Leone
25
South Africa
23
Liberia
21
Nigeria
21
West and Central Africa
18
Ethiopia
17
Western and Central Europe
17
Brazil
16
East and Southern Africa
16
Uganda
14
Africa
14
Latin America and the Carribbean
13
Congo, Democratic Republic of
11
Eastern Europe
11
Russia
10
Guinea
9
Ghana
9
Zambia
9
Ukraine
9
South Sudan
8
Rwanda
8
Malawi
8
Philippines
7
Nepal
7
Germany
7
Tanzania
7
Mozambique
7
Middle East and North Africa
7
South–East Asia Region
7
Zimbabwe
6
Syria
6
Bangladesh
6
Cambodia
4
Namibia
4
Myanmar / Burma
4
Asia
4
Vietnam
4
Burkina Faso
3
Senegal
3
USA
3
Lebanon
3
Thailand
3
Indonesia
3
Chile
3
Eastern Europe and Central Asia
3
Paraguay
3
United Kingdom
3
Guinea-Bissau
2
Cameroon
2
Jordan
2
Turkey
2
China
2
Sudan
2
Argentina
2
Botswana
2
Angola
2
Lesotho
2
Spain
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Niger
1
Haiti
1
Pakistan
1
Iraq
1
Gambia
1
Malaysia
1
Papua New Guinea
1
Central African Republic
1
Peru
1
Eswatini/ Swaziland
1
Honduras
1
Ecuador
1
Yemen
1
Western Pacific Region
1
Venezuela
1
Southern Africa
1
Laos
1
Bulgaria
1
Gabon
1
Japan
1
France
1
Tunisia
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
296
Clinical Guidelines
145
Women & Child Health
64
Public Health
58
Key Resources
23
Pharmacy & Technologies
14
Capacity Building
4
Toolboxes
COVID-19
282
TB
91
HIV
81
Ebola
67
Rapid Response
55
NTDs
44
AMR
31
Pharmacy
26
Global Health Education
16
Refugee
15
Mental Health
15
Planetary Health
14
Health Financing Toolbox
14
Conflict
12
NCDs
12
Polio
11
Zika
11
Caregiver
11
Cholera
10
Disability
2
Natural Hazards
1
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a...
Humanitarian emergencies, regardless of type and cause, have a number of common risk factors for communicable diseases inextricably linked to excess risk of morbidity and mortality which can come from vaccine–preventable diseases (VPDs). The reduc...
Diarrhea is one of the world’s leading causes of child illness and death, and rotavirus is the most common cause of severe diarrhea. Yet it can be prevented and treated. There is a vaccine. And while hundreds of thousands of children in India will...
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie...
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, ... manufacturers, health professionals, researchers, the scientific media and the general public.
Les notes de synthèse s’adressent aux responsables nationaux de la santé publique et aux administrateurs des programmes de vaccination, mais elles peuvent également présenter un intérêt pour les organismes internationaux de financement, les groupes consultatifs sur la vaccination, les fabricants de vaccins, les professionnels de la santé, les chercheurs, les médias scientifiques et le grand public.
Sleeping sickness is controlled by case detection and treatment but this often only reaches less than 75% of the population. Vector control is capable of completely interrupting HAT transmission but is not used because of expense. We conducted a full scale field ... of a refined vector control technology. From preliminary trials we determined the number of insecticidal tiny targets required to control tsetse populations by more than 90%. We then carried out a full scale, 500 km2 field trial covering two HAT foci in Northern Uganda (overall target density 5.7/km2). In 12 months tsetse populations declined by more than 90%. A mathematical model suggested that a 72% reduction in tsetse population is required to stop transmission in those settings. The Ugandan census suggests population density in the HAT foci is approximately 500 per km2. The estimated cost for a single round of active case detection (excluding treatment), covering 80% of the population, is US$433,333 (WHO figures). One year of vector control organised within country, which can completely stop HAT transmission, would cost US$42,700. The case for adding this new method of vector control to case detection and treatment is strong. We outline how such a component could be organised.
Non-pharmaceutical interventions (NPI) are public health measures that aim to prevent and/or control SARS-CoV-2 transmission in the community. As long as there is no effective and safe vaccine to protect those at risk of severe COVID-19, NPI are the...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have ho...
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe dis...
Humanitarian emergencies result in a breakdown of critical health-care services and often make vulnerable communities dependent on external agencies for care. In resource-constrained settings, this may occur against a backdrop of extreme poverty, malnutrition, insecurity, low literacy and poor infra...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...
“Guide to facilitate the implementation of the WHO/UNICEF “Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines” for Africa
t contains action-oriented lists of critical topics to address and checklists tailored to the context of African Union Member States.
...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
mnesty International’s annual report on the state of the world’s human rights in 2021, published in March 2022, shows that promises to “build back better” after the Covid-19 pandemic were little more than lip service. Hopes of global cooperation withered in the face of ... hoarding and corporate greed.
Governments suppressed independent and critical voices, with some even using the pandemic as a pretext to shrink further the civic space. New and unresolved conflicts erupted or persisted. Those forced to flee were subjected to a litany of abuses, including pushbacks by countries in the Global North. But hopes for a better post-pandemic world were kept alive by courageous individuals, social movements and civil society organizations.
The report is available in different languages
BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
Annual and medium-term budget preparation processes are the platforms through which specific plans are transformed into actual resource allocation decisions. The aim of this Process Guide is to support key stakeholders involved in these processes (such as the Cabinet, Ministries of Finance and Healt...
The article focuses on "The State of the World’s Children 2023" report published by UNICEF. It highlights the critical role of vaccines in saving lives and the challenges in global immunization efforts, especially for marginalized and underserved children. The report emphasizes the impact of COVID...
